- Category
- Micro (2023-24)
- Udyam number
- UDYAM-TS-09-0056575

Receps Limited
About Receps Limited
Data last updated:
Receps Limited is a public limited company based in Hyderabad, Telangana, India, a subsidiary of Visakha Pharmacity Limited. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 12 May 2022.
The company is registered with the Registrar of Companies (ROC), Hyderabad, under CIN U24239TG2022PLC162610. Its GSTIN is 37AALCR8634D1Z3 (Andhra Pradesh).
The company has an authorised share capital of ₹15 Lakh and a paid-up capital of ₹10 Lakh. It is led by directors including Eshwar Reddy Purmandla and Popuri Pandari Lal Krishna.
Its last annual general meeting (AGM) was held on 11 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 136/2 And 4 7th Floor Ramky Grandiose Gachibowli, Hyderabad, Telangana, India – 500032.
As per the financials filed for FY 2025, the company reported a revenue of ₹9.2 Cr, a growth of 65% compared to the previous year. For the same year it recorded a net loss of ₹70,000 (net margin -0.1%) and EBITDA of ₹3.14 Cr (EBITDA margin 34.1%).
The company has about 89 employees on its provident fund (EPFO) records.
Receps Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-TS-09-0056575). The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Recognitions & Rankings of Receps
Contact details
Receps Limited's registered office is in Hyderabad, Telangana. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered Address136/2 And 4 7th Floor Ramky Grandiose Gachibowli, Hyderabad, Telangana, India – 500032
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Receps Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Receps is professional, scientific and technical. In detail, this covers scientific research and development.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| M | Professional, Scientific and Technical | M5 | Scientific research and development |
To see the full business activity and turnover split of Receps Limited, buy the company report.
Financials of Receps Limited
FY 2025 filings availableReceps Limited reported revenue of ₹9.2 Cr (up 65% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue rose 65% in the latest year. EBITDA rose 91% in the latest year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 |
|---|---|---|---|
| Profit and Loss Statement | |||
| Revenue from Operations | |||
| Other Income | |||
| Total Revenue | |||
| Cost of Materials Consumed | |||
| Employee Benefit Expense | |||
| Finance Costs | |||
| Depreciation and Amortisation | |||
| Other Expenses | |||
| Total Expenses | |||
| EBITDA | ₹3.14 Cr | ||
| Profit Before Tax | |||
| Tax Expense | |||
| Net Profit (PAT) | -₹70,000 | ||
| Balance Sheet | |||
| Share Capital | |||
| Reserves and Surplus | |||
| Net Worth (Total Equity) | |||
| Long-term Borrowings | |||
| Short-term Borrowings | |||
| Trade Payables | |||
| Total Liabilities | |||
| Fixed Assets | |||
| Investments | |||
| Inventories | |||
| Trade Receivables | |||
| Cash and Bank Balance | |||
| Total Assets | |||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 |
|---|---|---|---|
| Profitability | |||
| EBITDA Margin | 34.1% | ||
| Net Profit Margin | -0.1% | ||
| Return on Equity (ROE) | |||
| Return on Capital Employed (ROCE) | |||
| Return on Assets (ROA) | |||
| Liquidity and Debt | |||
| Current Ratio | |||
| Quick Ratio | |||
| Debt-to-Equity Ratio | |||
| Interest Coverage Ratio | |||
| Efficiency and Growth | |||
| Asset Turnover | |||
| Receivable Days | |||
| Payable Days | |||
| Inventory Days | |||
| Revenue Growth | |||
| Net Profit Growth | |||
To see the full financial statements and ratios of Receps Limited, buy the company report.
Board of directors of Receps Limited
Receps has 3 current directors and 6 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Siva Satyanarayana Reddy Manda | Nominee Director | 18 Mar 2024 | 2 Years 8 Months | Current |
| Eshwar Reddy Purmandla Also directs: Ramky Infrastructure Limited, Visakha Pharmacity Limited, Eco Carbon Engineering Solutions Limited and 5 more | Director | 05 Nov 2022 | 4 Years 0 Months | Current |
| Popuri Pandari Lal Krishna Also directs: Visakha Pharmacity Limited, Eco Carbon Engineering Solutions Limited, Visakha Energy Limited and 3 more | Director | 05 Nov 2022 | 4 Years 0 Months | Current |
Peer comparison
Receps Limited is compared with the 3 companies closest to it by revenue in the Pharma industry (Contract Research), with the same principal business activity (scientific research and development), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Novumgen Private Limited | ₹9.49 Cr (FY 2024) | 77.0% | Vadodara, Gujarat, India | |||
| Receps Limitedthis company | ₹9.2 Cr (FY 2025) | -₹70,000 | -0.1% | 65.0% | 89 | Hyderabad, Telangana, India |
| Taraasian Drugs Private Limited | ₹9.17 Cr (FY 2025) | 21.0% | Aurangabad, Maharashtra, India | |||
| Airis Pharma Private Limited | ₹9.06 Cr (FY 2024) | 29.0% | Telangana, India |
To see the full peer comparison of Receps Limited, buy the company report.
Auditor
Receps Limited is audited by A B V & Associates for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| A B V & Associates | FY 2023 | 004937S |
Shareholding
The shareholding of Receps Limited is on record for FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 |
|---|---|
| Promoters | |
| Domestic institutional investors (DII) | |
| Foreign institutional investors (FII) | |
| Public | |
| Others |
To see the full shareholding pattern of Receps Limited, buy the company report.
Legal cases
No court or tribunal cases involving Receps Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
Receps Limited has 2 MSME Form 1 returns on record for the period ending Mar 2023, listing 38 overdue payments to 4 micro and small suppliers. Companies must report dues to micro and small suppliers that stay unpaid for more than 45 days in a half-yearly MSME Form 1 return.
Suppliers with reported dues (4 of 4)
| Supplier | Amount due | Due since | Reported on |
|---|---|---|---|
| Sri Sai Durga Scientifics | |||
| an individual supplier | |||
| Chromatography World | |||
| Production Needs Gases Private Limited |
To see the full MSME payment records of Receps Limited, buy the company report.
Individuals and sole proprietors among the suppliers are not named.
Employees & EPFO
Receps Limited has a workforce of 89 employees on its EPFO records as of May 2026, across 1 active EPFO establishment.
Headcount by financial year
| Financial year | Employees (EPFO) |
|---|---|
| FY 2026-27 | 89 |
| FY 2025-26 | |
| FY 2024-25 | |
| FY 2023-24 | |
| FY 2022-23 |
To see the full employee and EPFO history of Receps Limited, buy the company report.
GST
Receps has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 37AALCR8634D1Z3 | Andhra Pradesh | Active | 01 Jul 2022 |
To see the full GST registrations and return filing status of Receps Limited, buy the company report.
Recent activity
Receps Limited has 9 board changes on record since 2022: 3 appointments and 6 cessations. The latest: Siva Satyanarayana Reddy Manda was appointed as Nominee Director on 18 Mar 2024.
Frequently asked questions
Receps is an active public limited company based in Hyderabad, Telangana, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 12 May 2022 (4+ years old) and is registered under CIN U24239TG2022PLC162610.
Receps has 3 current directors:
- Siva Satyanarayana Reddy Manda - Nominee Director
- Eshwar Reddy Purmandla - Director
- Popuri Pandari Lal Krishna - Director
The latest financial statements of Receps on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 11 September 2025. Year-wise statements from FY 2023 are in the company report.
The GSTIN of Receps is 37AALCR8634D1Z3, registered in Andhra Pradesh.
The CIN (Corporate Identification Number) of Receps is U24239TG2022PLC162610. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Receps was incorporated on 12 May 2022, making it 4+ years old. It is registered with the Registrar of Companies, Hyderabad.
The peers of Receps by revenue are Novumgen Private Limited, Taraasian Drugs Private Limited, Airis Pharma Private Limited, all in the Pharma industry (Contract Research), with the same principal business activity (scientific research and development).
Siva Satyanarayana Reddy Manda was appointed as Nominee Director on 18 Mar 2024. Eshwar Reddy Purmandla ceased to be Additional Director on 29 Sep 2023. Popuri Pandari Lal Krishna ceased to be Additional Director on 29 Sep 2023. Receps has 9 board changes on record in total.
Yes, Receps is registered as a micro enterprise under Udyam registration (number: UDYAM-TS-09-0056575).
Receps has 2 MSME Form 1 returns on record for the period ending Mar 2023, listing 38 overdue payments to 4 micro and small suppliers. The latest return was filed on 27 Aug 2023.
The registered office of Receps is at 1362 And 4 7th Floor Ramky Grandiose Gachibowli, Hyderabad, Telangana, India – 500032.
Receps operates in the pharma industry, in the drug formulation and development segment.

